Rankings
▼
Calendar
SNDX Q1 2021 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$379,000
+0.0% YoY
Gross Profit
$379,000
100.0% margin
Operating Income
-$27M
-7167.0% margin
Net Income
-$28M
-7314.8% margin
EPS (Diluted)
$-0.54
QoQ Revenue Growth
-0.3%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$280M
Total Liabilities
$51M
Stockholders' Equity
$228M
Cash & Equivalents
$64M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$379,000
$379,000
+0.0%
Gross Profit
$379,000
$379,000
+0.0%
Operating Income
-$27M
-$15M
-79.9%
Net Income
-$28M
-$15M
-82.0%
← FY 2021
All Quarters
Q2 2021 →